Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F P Smith

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1985
Presentation and management of parasellar and suprasellar metastatic mass lesionsJ C Kattah, R M Silgals, H Manz, et al.
Investigational New Drugs|September 1, 1988
Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapyM McCabe, F P Smith, J S Macdonald, et al.
Cancer Research|October 1, 1981
Phase I trial and clinical pharmacology of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosoureaP V Woolley, P V Luc, A Rahman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1983
Combination chemotherapy for locally advanced pancreatic cancer: equivalence to external beam irradiation and implication for future managementF P Smith, D Stablein, S Korsmeyer, et al.
Cancer|April 1, 1979
5-Fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy for adenocarcinoma of the lungT P Butler, J S MacDonald, F P Smith, et al.
Cancer Treatment Reports|March 1, 1981
Pulmonary disease as a complication of chlorozotocin chemotherapyJ D Ahlgren, F P Smith, D M Kerwin, et al.
American Journal of Clinical Oncology|February 1, 1984
Treatment of advanced breast cancer with two doxorubicin-containing regimensM A Harris, P J Byrne, F P Smith, et al.
Cancer Treatment Reports|November 1, 1981
Phase II study of PCNU in colorectal carcinomaE P Mitchell, J Y Killen, F P Smith, et al.
Cancer|October 1, 1980
A phase II study of chlorozotocin in metastatic malignant melanomaD F Hoth, P S Schein, S Winokur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1985
A controlled trial of the effect of 4-hydroxypyrazolopyrimidine (allopurinol) on the toxicity of a single bolus dose of 5-fluorouracilP V Woolley, M J Ayoob, F P Smith, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1985
Presentation and management of parasellar and suprasellar metastatic mass lesionsJ C Kattah, R M Silgals, H Manz, et al.
Investigational New Drugs|September 1, 1988
Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapyM McCabe, F P Smith, J S Macdonald, et al.
Cancer Research|October 1, 1981
Phase I trial and clinical pharmacology of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosoureaP V Woolley, P V Luc, A Rahman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1983
Combination chemotherapy for locally advanced pancreatic cancer: equivalence to external beam irradiation and implication for future managementF P Smith, D Stablein, S Korsmeyer, et al.
Cancer|April 1, 1979
5-Fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy for adenocarcinoma of the lungT P Butler, J S MacDonald, F P Smith, et al.
Cancer Treatment Reports|March 1, 1981
Pulmonary disease as a complication of chlorozotocin chemotherapyJ D Ahlgren, F P Smith, D M Kerwin, et al.
American Journal of Clinical Oncology|February 1, 1984
Treatment of advanced breast cancer with two doxorubicin-containing regimensM A Harris, P J Byrne, F P Smith, et al.
Cancer Treatment Reports|November 1, 1981
Phase II study of PCNU in colorectal carcinomaE P Mitchell, J Y Killen, F P Smith, et al.
Cancer|October 1, 1980
A phase II study of chlorozotocin in metastatic malignant melanomaD F Hoth, P S Schein, S Winokur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1985
A controlled trial of the effect of 4-hydroxypyrazolopyrimidine (allopurinol) on the toxicity of a single bolus dose of 5-fluorouracilP V Woolley, M J Ayoob, F P Smith, et al.
Pageof 11